Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Return on Sales (2021)

Cullinan Therapeutics has reported Return on Sales over the past 1 years, most recently at 3.56% for Q4 2021.

  • Quarterly results put Return on Sales at 3.56% for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was 3.56% (changed N/A YoY), and the annual figure for FY2021 was 3.56%, changed.
  • Return on Sales for Q4 2021 was 3.56% at Cullinan Therapeutics, down from 3.29% in the prior quarter.
  • Over the last five years, Return on Sales for CGEM hit a ceiling of 0.07% in Q1 2021 and a floor of 3.56% in Q4 2021.